- Clinical immunology of atherosclerosis – from the theory to practice
- Application of photodynamic therapy in the pathology of the vascular wall
- A prospective study CRISTALL part 1
- Optimal antiplatelet therapy in patients with acute coronary syndrome, undergoing to primary percutaneous coronary angioplasty
- Mutations’ level detection of mitochondrial genome G14459A in homogenates of the human aortic intima
- Safety of statins in the treatment of patients with high risk of cardiovascular complications and hepatic pathology

Download Abstracts

- Russian atherosclerosis recommendations V revision
- Evolution of the knowledge about pro-and antiatherogenic properties of lipoproteins
- Associations between the level and activity of secretory phospholipase A2 group IIA and the severity of coronary atherosclerosis.
- The cholesterol level in Russian adults aged 20-70 years
- Secretory phospholipase A2 and the development of atherosclerosis
- Сombination of thrombolytic therapy and percutaneous coronary interventions in treatment of ST elevation myocardial infarction

Download Abstracts

- Endovascular treatment of unprotected left main coronary artery disease
- Endothelial progenitor cells and atherosclerotic process
- Monocytes in the development and destabilization of atherosclerotic plaques
- The influence of chemokines on the formation of atherosclerotic lesions by regulating the function of leukocytes
- High dietary content of palmitic fatty acid is the major cause of increase in low-density lipoprotein cholesterol and arterial intima atheromatosis
- Heterozygous familial hypercholesterolemia in St.-Petersburg due to defects of the low density lipoprotein receptor gene

Download Abstracts

- Clinical and angiographic assessment of immediate and remote results of the use of drug-coated stents (sirolimus-eluting stents and everolimus-eluting stents) in patients with ischemic heart disease.
- Subclinical atherosclerosis as cardiovascular events risk factor.
- Elderly patients with coronary artery disease and chronic heart failure. The results of the use of simvastatin.
- Oxidative modification of lipids and proteins in men with coronary atherosclerosis complication.
- Regression of coronary atherosclerosis in patients with coronary artery disease and high levels of Lp (a) after a long course of Lp (a) apheresis.
- Differential diagnosis of high hypercholesterolemia (clinical case).

Download Abstracts

- Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
- The level of PCSK9 in patients with familial hypercholesterolemia
- The correction of lipid metabolism and markers of inflammation by diet and HMG-CoA reductase inhibitors in patients with a different forms of hyperlipidemia
- Assessment of the effectiveness of TULIP. The results of observational studies "Compliance."
- Statins in the treatment of chronic heart failure
- Inhibition of cholesterol absorption in the enterocytes

Download Abstracts

- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).